Allergy Therapeutics (AGY.LSE) Q3 2026 Earnings

30SepConfirmed
Q3 2025
Q4 2025
Q1 2026
Next
-0.53
-0.48
-0.44
-0.39

Details

Expected EPS
-0.48100504183894816
Actual EPS
N/A
Surprise EPS
0.48
Surprise Percent
+100%

Description

Allergy Therapeutics (AGY.LSE) will report earnings of for Q3 2026 on September 30, 2026.

0 Comments

Share your thoughts